A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.

Thirty-four evaluable patients were treated with vinorelbine, a novel, semisynthetic vinca alkaloid, as first-line chemotherapy for advanced breast cancer. They received vinorelbine 25 mg m-2 i.v. given weekly for a maximum of 16 cycles. Two patients achieved a complete remission and 15 a partial re...

Full description

Saved in:
Bibliographic Details
Main Authors: Twelves, C. J., Dobbs, N. A., Curnow, A., Coleman, R. E., Stewart, A. L., Tyrrell, C. J., Canney, P., Rubens, R. D.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 1994
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033534/
https://ncbi.nlm.nih.gov/pubmed/7947109
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items